Article
In-Depth Quantitative Proteomics Characterization of In Vitro Selected Miltefosine Resistance in Leishmania infantum
Registro en:
SABOIA-VAHIA, Leonardo et al. In-Depth Quantitative Proteomics Characterization of In Vitro Selected Miltefosine Resistance in Leishmania infantum. Proteomes, v. 10, n. 10, p. 1 - 21, Mar. 2022.
2227-7382
10.3390/ proteomes10020010
Autor
Saboia-Vahia, Leonardo
Cuervo, Patricia
Wisniewski, Jacek R.
Lopes, Geovane Dias
Pinho, Natalia
Padrón, Gabriel
Varotti, Fernando de Pilla
Murta, Silvane Maria Fonseca
Resumen
Visceral leishmaniasis (VL) is a neglected disease caused by Leishmania parasites. Although
significant morbidity and mortality in tropical and subtropical regions of the world are associated
with VL, the low investment for developing new treatment measures is chronic. Moreover, resistance
and treatment failure are increasing for the main medications, but the emergence of resistance
phenotypes is poorly understood at the protein level. Here, we analyzed the development of resistance
to miltefosine upon experimental selection in a L. infantum strain. Time to miltefosine resistance
emergence was ~six months and label-free quantitative mass-spectrometry-based proteomics analyses
revealed that this process involves a remodeling of components of the membrane and mitochondrion,
with significant increase in oxidative phosphorylation complexes, particularly on complex IV and
ATP synthase, accompanied by increased energy metabolism mainly dependent on -oxidation of
fatty acids. Proteins canonically involved in ROS detoxification did not contribute to the resistant
process whereas sterol biosynthesis enzymes could have a role in this development. Furthermore,
changes in the abundance of proteins known to be involved in miltefosine resistance such as ABC
transporters and phospholipid transport ATPase were detected. Together, our data show a more
complete picture of the elements that make up the miltefosine resistance phenotype in L. infantum.